Insights+ Exclusive: COVID-19 Healthcare News Updates

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding and regulatory guidelines related to the COVID-19 from Jan to date.


8. CureVac Extended its Collaboration with CEPI to Develop Vaccine Against Coronavirus nCoV-2019

Jan 31, 2020 | Collaboration

7. Inovio Collaborated with Beijing Vaccine to Advance the Development of INO-4800 Vaccine Targeting Coronavirus in China

Jan 31, 2020 | Collaboration

6. Sorrento Collaborated with Celularity to Initiate the Development of Emergency Allogeneic Natural Killer Cell Therapy for Coronavirus Infection

Jan 30, 2020 | Collaboration

5. Johnson & Johnson Initiated the Development of Vaccines Against Coronavirus

Jan 29, 2020 | Collaboration

4. GeoVax Collaborated with BravoVax Collaborate to Develop Vaccine for Coronavirus  

Jan 27, 2020 | Collaboration

3. Takis Signed an Agreement with Evvivax to Develop a 2019-nCoV Coronavirus vaccine

Jan 27, 2020 | Collaboration

2. Moderna Signed a Research Partnership with the CEPI to Develop an mRNA Vaccine Against 2019-nCoV

Jan 23, 2020 | Grant

1. Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus

Jan 23, 2020 | Grant

Source: Company Press releases, official announcements | Image source: Unsplash

Disclaimer: Above news updates are a summarization of key news we have collected from public sources